SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024378
Filing Date
2019-05-08
Accepted
2019-05-08 08:01:27
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519604_10q.htm 10-Q 498378
2 EXHIBIT 31.1 tv519604_ex31-1.htm EX-31.1 9367
3 EXHIBIT 31.2 tv519604_ex31-2.htm EX-31.2 9438
4 EXHIBIT 32.1 tv519604_ex32-1.htm EX-32.1 3237
5 EXHIBIT 32.2 tv519604_ex32-2.htm EX-32.2 3371
  Complete submission text file 0001144204-19-024378.txt   5021053

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20190331.xml EX-101.INS 1539970
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20190331.xsd EX-101.SCH 27853
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20190331_cal.xml EX-101.CAL 34652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20190331_def.xml EX-101.DEF 210115
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20190331_lab.xml EX-101.LAB 255741
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20190331_pre.xml EX-101.PRE 245419
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 19805235
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences